Vimta Lab IHnS and now new BO
#VimyaLab had BO of IhnS at 330 level and now again a BO at 450 levels.
Can be added for 34% upside from here for 610.
CMP 461 Qtr Sales growth is flat but ROCE is healthy.
Can be added for 34% upside from here for 610.
CMP 461 Qtr Sales growth is flat but ROCE is healthy.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。